21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Medicine Compliance Aid Stability
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Should be stored in an airtight container.
19 January 2022
Lactation Safety Information
No published evidence of safety
Mesalazine, of which balsalazide is the active metabolite, has been associated with a small number of possible cases of diarrhoea in breastfed infants
Monitor infant for diarrhoea
4 August 2020